Rosalind “Roz” Brewer is set to take over as CEO of Walgreens Boots Alliance effective March 15, succeeding Stefano Pessina, who has led the company since 2015.
The Everstone Group is investing up to $50 million in Series B funding to expand and accelerate Slayback's pipeline of complex generic and specialty pharmaceutical products.
The company is selling Alliance Healthcare to AmerisourceBergen for $6.5 billion in a cash-and-stock transaction comprised of $6.3 billion in cash and 2 million shares of AmerisourceBergen common stock.
